It also inhibited the increase of Tregs and TGF-β and IL-10, while promoted CD8+ T cells infiltration in tumor tissues, reducing the exhaustion phenotype of T cells and maintaining lymphocyte cytotoxicity [154]. The gene discussed is TGFB1; the disease is neoplasm.